Ubs Asset Management Americas Inc Axsome Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 74,892 shares of AXSM stock, worth $7.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,892
Previous 57,642
29.93%
Holding current value
$7.58 Million
Previous $4.88 Million
79.09%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AXSM
# of Institutions
407Shares Held
36.2MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$393 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$334 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$296 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$171 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$98.9 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.34B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...